Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM

Carcinogenesis

Volumn 31, Issue 5, 2009, Pages 880-885

  Cheung, Ka Lung ^a   Khor, Tin Oo ^a   Huang, Mou Tuan ^a   Kong, Ah Ng ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BIM PROTEIN; CASPASE 3; CASPASE 7; DEXTRAN SULFATE; DIBENZOYLMETHANE DERIVATIVE; PHENETHYL ISOTHIOCYANATE; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR NRF2; ANTINEOPLASTIC AGENT; CHALCONE DERIVATIVE; DIBENZOYLMETHANE; ISOTHIOCYANIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; COLON CANCER; COLON POLYP; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; IN VIVO STUDY; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CYCLE; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; DRUG EFFECT; INTESTINE MUCOSA; INTESTINE POLYP; PATHOLOGY;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; AZOXYMETHANE; BODY WEIGHT; CELL CYCLE; CHALCONES; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; INTESTINAL MUCOSA; INTESTINAL POLYPS; ISOTHIOCYANATES; MALE; MICE; MICE, INBRED C57BL;

EID: 77952314234     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp285     Document Type: Article

References (26)

1. Horner, M.J. et al. (1975-2006) SEER Cancer Statistics Review. National Cancer Institute, Bethesda, MD.
2. Moser, A.R. et al. (1995) ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer, 31A, 1061-1064.
3. Bird, R.P. et al. (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett., 15, 395-402.
4. Bird, R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
5. Tanaka, T. et al. (2007) Inhibition of colon carcinogenesis by dietary nonnutritive compounds. J. Toxicol. Pathol., 20, 215-235.
6. Itzkowitz, S.H. et al. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G7-G17.
7. Okayasu, I. et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology, 98, 694-702.
8. Clapper, M.L. et al. (2007) Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol. Sin., 28, 1450-1459.
9. Cheung, K.L. et al. (2008) PEITC induces G1 cell cycle arrest on HT-29 cells through the activation of p38 MAPK signaling pathway. AAPS J., 10, 277-281.
10. Yin, P. et al. (2009) Phenethyl isothiocyanate induces cell cycle arrest and reduction of alphaand beta-tubulin isotypes in human prostate cancer cells. Cell Biol. Int., 33, 57-64.
11. Mi, L. et al. (2008) Binding to protein by isothiocyanates: a potential mechanism for apoptosis induction in human nonsmall lung cancer cells. Nutr. Cancer, 60 (suppl 1), 12-20.
12. Trachootham, D. et al. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell, 10, 241-252.
13. Xu, C. et al. (2006) Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol. Cancer Ther., 5, 1918-1926.
14. Mi, L. et al. (2008) Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J. Biol. Chem., 283, 22136-22146.
15. Stoner, G.D. et al. (2008) Carcinogen-altered genes in rat esophagus positively modulated to normal levels of expression by both black raspberries and phenylethyl isothiocyanate. Cancer Res., 68, 6460-6467.
16. Barve, A. et al. (2008) Murine prostate cancer inhibition by dietary phytochemicals-curcumin and phenyethylisothiocyanate. Pharm. Res., 25, 2181-2189.
17. Conaway, C.C. et al. (2005) Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res., 65, 8548-8557.
18. Chung, F.L. et al. (2000) Chemoprevention of colonic aberrant crypt foci in Fischer rats by SFN and PEITC. Carcinogenesis, 21, 2287-2291.
19. Plate, A.Y. et al. (2006) Effects of indole-3-carbinol and phenethyl isothiocyanate on colon carcinogenesis induced by azoxymethane in rats. Carcinogenesis, 27, 287-292.
20. Singletary, K. et al. (1998) Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7, 12-dimethylbenz[a]anthracene. Carcinogenesis, 19, 1039-1043
21. Shen, G. et al. (2007) Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res., 67, 9937-9944.
22. Frazier, M.C. et al. (2004) Proteomic analysis of proteins altered by dibenzoylmethane in human prostatic cancer LNCaP cells. Proteomics, 4, 2814-2821.
23. Hong, J. et al. (2004) Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25, 1671-1679.
24. Thimmulappa, R.K. et al. (2008) Dibenzoylmethane activates Nrf2dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs. Med. Chem., 4, 473-481.
25. Khor, T.O. et al. (2009) Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model. Cancer Res., 69, 7096-7102.
26. Lin, C.C. et al. (2001) Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice. Cancer Lett., 168, 125-132.